CASP1 and Alzheimer disease: Furthermore, the monocytes of patients with AD that were LPS-primed and Aβ42-stimulated have shown an increased expression of NLRP3 inflammasome components such as NLRP3, PYCARD, caspase-1, and its effectors: IL-18 and IL-1β [61].